Live Breaking News & Updates on Simcere Pharmaceutical Company

Stay updated with breaking news from Simcere pharmaceutical company. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

SIMCERE PHARMA (HK.2096) to host 2022 R&D Day

/PRNewswire/ SIMCERE PHARMA (HK.2096), an innovation and R&D-driven pharmaceutical company with a mission of "providing today s patients with medicines of. ....

Jason Bao ,

Simcere: SIMCERE PHARMA (HK.2096) to host 2022 R&D Day

HONG KONG, April 7, 2022 /PRNewswire/ SIMCERE PHARMA (HK.2096), an innovation and R&D-driven pharmaceutical company with a mission of "providing today's patients with medicines of the future" ....

Ekevin Oliver , Ren Jinsheng , Jason Bao , Danny Chen , Bijoyesh Mookerjee , Simcere Pharmaceutical Group , Innovative Drug Development , National Key Laboratory Of Translational Medicine , Zhou Gaobo , Tang Renhong , Pharmaceutical Group , National Key Laboratory , Translational Medicine , Innovative Drug ,

DGAP-News: Vivoryon Therapeutics N.V.: Vivoryon Therapeutics and Simcere Announce CDE Approval of Chinese Clinical Trial Application for Varoglutamstat (SIM0408, PQ912) in Patients with Alzheimer's Disease

DGAP-News: Vivoryon Therapeutics N.V. / Key word(s): Miscellaneous Vivoryon Therapeutics N.V.: Vivoryon Therapeutics and Simcere Announce CDE Approval of Chinese Clinical Trial Application ....

Noord Holland , Renhong Tang , Jason Bao , Halle Saale , Sophia Hergenhan , Manuela Bader , Jian Hou , Michael Schaeffer , Simcere Pharmaceutical Group , Drug Administration , Trophic Communications , Simcere Pharmaceutical Group Ltd , Distribution Services , National Medical Products Administration , News Service , China Center , Vivoryon Therapeutics , Simcere Announce , Chinese Clinical Trial Application , Euronext Amsterdam , Drug Evaluation , Clinical Trial Application , Greater China , Executive Vice President , Chief Business Officer , Fast Track ,

Bijoyesh Mookerjee, M.D. named Chief Medical Officer, Oncology for Simcere Pharmaceuticals

/PRNewswire/ Simcere is thrilled to announce Bijoyesh Mookerjee, M.D., as our Chief Medical Officer, Oncology, of Simcere Pharmaceutical Group. Bijoyesh. ....

New York , United States , Jinsheng Ren , Bijoyesh Mookerjee , Simcere Pharmaceuticals , University Of Pune , National Cancer Institute , Downstate Medical Center , National Institutes Of Health , Thomas Jefferson University Sidney Kimmel Cancer Center , Glaxosmithkline Incyte Corporation , University Of New York , University Of Maryland Greenebaum Cancer Center , Johns Hopkins Oncology Center , Armed Forces Medical College , Global Clinical Program Head At Novartis Oncology , Company Chairman , Vice President , Senior Global Program Clinical Head , Executive Director , Global Clinical Program Head , Novartis Oncology , Incyte Corporation , Maryland Greenebaum Cancer Center , Johns Hopkins Oncology , National Institutes ,

Bijoyesh Mookerjee, M.D. named Chief Medical Officer, Oncology for Simcere Pharmaceuticals

/PRNewswire/ Simcere is thrilled to announce Bijoyesh Mookerjee, M.D., as our Chief Medical Officer, Oncology, of Simcere Pharmaceutical Group. Bijoyesh. ....

New York , United States , Jinsheng Ren , Bijoyesh Mookerjee , Simcere Pharmaceuticals , University Of Pune , National Cancer Institute , Downstate Medical Center , National Institutes Of Health , Thomas Jefferson University Sidney Kimmel Cancer Center , Glaxosmithkline Incyte Corporation , University Of New York , University Of Maryland Greenebaum Cancer Center , Johns Hopkins Oncology Center , Armed Forces Medical College , Global Clinical Program Head At Novartis Oncology , Company Chairman , Vice President , Senior Global Program Clinical Head , Executive Director , Global Clinical Program Head , Novartis Oncology , Incyte Corporation , Maryland Greenebaum Cancer Center , Johns Hopkins Oncology , National Institutes ,